• Search Research Projects
  • Search Researchers
  • How to Use
  1. Back to previous page

Development of immunotherapy targeting regulatory B cell for gastrointestinal cancer.

Research Project

Project/Area Number 26861091
Research Category

Grant-in-Aid for Young Scientists (B)

Allocation TypeMulti-year Fund
Research Field Digestive surgery
Research InstitutionFukushima Medical University

Principal Investigator

Saze Zenichiro  福島県立医科大学, 医学部, 助教 (10468126)

Project Period (FY) 2014-04-01 – 2016-03-31
Project Status Completed (Fiscal Year 2015)
Budget Amount *help
¥3,770,000 (Direct Cost: ¥2,900,000、Indirect Cost: ¥870,000)
Fiscal Year 2015: ¥780,000 (Direct Cost: ¥600,000、Indirect Cost: ¥180,000)
Fiscal Year 2014: ¥2,990,000 (Direct Cost: ¥2,300,000、Indirect Cost: ¥690,000)
KeywordsMDSC / 制御性B細胞 / 抑制性B細胞
Outline of Final Research Achievements

To verify whether low-density neutrophil cells have regulatory potential, we divided human PBMCs into low-density neutrophil cells and high-density cells. Then, we extracted CD15+ cells from each fraction, co-cultured with PBMCs under stimulation and measured INF-γ by ELISA. Suppression of INF-γ production was not observed in co-culture with high-density neutrophil cells. We were not able to examine suppression assay of co-culture with low-density neutrophil cells due to purity of CD15+ cells was low and the numbers of harvested low-density neutrophil cells from cancer patients were so small. Now we are trying to improve purity and quantity of low-density neutrophil cells. Using IHC, we analyzed correlation between CD15+ neutrophil in tumor and clinicopathological factors. No. of CD15+ cells of ly+ group was significantly higher than those of ly- group. We have plans to study about regulatory B cells from gastrointestinal cancer patients’ PBMC and tumor infiltrating lymphocytes.

Report

(3 results)
  • 2015 Annual Research Report   Final Research Report ( PDF )
  • 2014 Research-status Report

URL: 

Published: 2014-04-04   Modified: 2017-05-10  

Information User Guide FAQ News Terms of Use Attribution of KAKENHI

Powered by NII kakenhi